News Scangos to leave Biogen at a crossroads Company has grown, but direction towards next stage is unclear
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Merck KGaA acquires MS brain training software provider Merck KGaA will now integrate the technology into its MSdialog platform.
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
